Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 363

1.

An evidence-based staging system for cutaneous melanoma.

Balch CM, Soong SJ, Atkins MB, Buzaid AC, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF.

CA Cancer J Clin. 2004 May-Jun;54(3):131-49; quiz 182-4. Review.

2.

The revised American Joint Committee on Cancer staging system for melanoma.

Thompson JA.

Semin Oncol. 2002 Aug;29(4):361-9.

PMID:
12170439
3.

A new American Joint Committee on Cancer staging system for cutaneous melanoma.

Balch CM, Buzaid AC, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Houghton A Jr, Kirkwood JM, Mihm MF, Morton DL, Reintgen D, Ross MI, Sober A, Soong SJ, Thompson JA, Thompson JF, Gershenwald JE, McMasters KM.

Cancer. 2000 Mar 15;88(6):1484-91.

PMID:
10717634
4.

New TNM melanoma staging system: linking biology and natural history to clinical outcomes.

Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF.

Semin Surg Oncol. 2003;21(1):43-52. Review.

PMID:
12923915
5.

Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.

Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG, Fleming ID, Gershenwald JE, Houghton A Jr, Kirkwood JM, McMasters KM, Mihm MF, Morton DL, Reintgen DS, Ross MI, Sober A, Thompson JA, Thompson JF.

J Clin Oncol. 2001 Aug 15;19(16):3635-48. Review.

PMID:
11504745
6.

[Experiences with the new American Joint Committee on Cancer (AJCC) classification of cutaneous melanoma].

Eigentler TK, Radny P, Kamin A, Weide B, Caroli UM, Garbe C.

J Dtsch Dermatol Ges. 2005 Aug;3(8):592-8. Review. German.

PMID:
16033477
7.

The new melanoma staging system.

Kim CJ, Reintgen DS, Balch CM; AJCC Melanoma Staging Committee.

Cancer Control. 2002 Jan-Feb;9(1):9-15. Review.

PMID:
11907461
8.

Revised American Joint Committee on Cancer staging criteria accurately predict sentinel lymph node positivity in clinically node-negative melanoma patients.

Rousseau DL Jr, Ross MI, Johnson MM, Prieto VG, Lee JE, Mansfield PF, Gershenwald JE.

Ann Surg Oncol. 2003 Jun;10(5):569-74.

PMID:
12794025
9.

Classification and staging of melanoma.

Gershenwald JE, Buzaid AC, Ross MI.

Clin Lab Med. 2000 Dec;20(4):785-815. Review.

PMID:
11221515
10.

Cutaneous melanoma: prognosis and treatment results worldwide.

Balch CM.

Semin Surg Oncol. 1992 Nov-Dec;8(6):400-14.

PMID:
1439450
11.

A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods.

Balch CM, Murad TM, Soong SJ, Ingalls AL, Halpern NB, Maddox WA.

Ann Surg. 1978 Dec;188(6):732-42.

12.

Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma.

Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U, Kortmann RD, Kettelhack C, Frerich B, Keilholz U, Dummer R, Sebastian G, Tilgen W, Schuler G, Mackensen A, Kaufmann R.

Melanoma Res. 2007 Dec;17(6):393-9.

PMID:
17992123
13.

Single-institution experience in the management of patients with clinical stage I and II cutaneous melanoma: results of sentinel lymph node biopsy in 240 cases.

Rex J, Paradelo C, Mangas C, Hilari JM, Fernández-Figueras MT, Fraile M, Alastrué A, Ferrándiz C.

Dermatol Surg. 2005 Nov;31(11 Pt 1):1385-93.

PMID:
16416605
14.

N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.

Rossi CR, Mocellin S, Pasquali S, Pilati P, Nitti D.

Ann Surg Oncol. 2008 Jan;15(1):310-5. Epub 2007 Nov 7.

PMID:
17987346
15.

The new staging system for cutaneous melanoma in the era of lymphatic mapping.

Rousseau DL Jr, Gershenwald JE.

Semin Oncol. 2004 Jun;31(3):415-25. Review.

PMID:
15190500
16.

Prognostic histopathological factors in malignant melanoma.

Shaw HM, Balch CM, Soong SJ, Milton GW, McCarthy WH.

Pathology. 1985 Apr;17(2):271-4.

PMID:
4047730
17.

Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.

Nowecki ZI, Rutkowski P, Kulik J, Siedlecki JA, Ruka W.

Br J Dermatol. 2008 Sep;159(3):597-605. doi: 10.1111/j.1365-2133.2008.08710.x. Epub 2008 Jul 4.

PMID:
18616789
19.

Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial.

Balch CM, Soong S, Ross MI, Urist MM, Karakousis CP, Temple WJ, Mihm MC, Barnhill RL, Jewell WR, Wanebo HJ, Harrison R.

Ann Surg Oncol. 2000 Mar;7(2):87-97.

PMID:
10761786
20.

Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.

Niakosari F, Kahn HJ, McCready D, Ghazarian D, Rotstein LE, Marks A, Kiss A, From L.

Arch Dermatol. 2008 Apr;144(4):462-7. doi: 10.1001/archderm.144.4.462.

PMID:
18427039

Supplemental Content

Support Center